Computational identification of metabolites for pathways related to Huntington's disease

被引:0
|
作者
Christodoulou, Christiana C. [1 ,2 ]
Minadakis, George [3 ]
Demetriou, Christiana A. [4 ]
Zamba-Papanicolaou, Eleni
Spyrou, George M.
机构
[1] Cyprus Inst Neurol & Genet, Neurol Clin & Bioinformat Grp, Engomi, Cyprus
[2] Cyprus Sch Mol Med, Engomi, Cyprus
[3] Cyprus Inst Neurol & Genet, Bioinformat Grp, Engomi, Cyprus
[4] Univ Nicosia, Sch Med, Dept Primary Care & Populat, Engomi, Cyprus
关键词
Huntington's disease; Metabolomics; Systems Bioinformatics; PathwayConnector; DOPAMINE;
D O I
10.1109/BIBE.2019.00155
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Huntington's disease (HD), a rare autosomal dominant disease, affecting the medium spiny neurons of the CNS. Although HD is caused by a trinucleotide repeat in the HTT gene, it is a complex disease. Systems Bioinformatics which combines systems biology and bioinformatics, has the ability to reveal synergistic relationships between multiple entities. This approach is vital as it can shed light on the biological behavior and mechanisms of the cell rather than only trying to study and understand a part of the system. Metabolomics is the systematic study and measurement of metabolites within a biological sample. In this work, we employ two approaches to identify metabolites for HD-related pathways, which were previously identified from our previous work on multi-source data integration These include: i) creation of pathway-to-pathway networks based on the reference network of PathwayConnector where pathways are mapped based on connectivity on KEGG, and (ii) creation of pathway-to-pathway networks using a pairwise approach, where a connection between two pathways exists only if they share common metabolites.
引用
收藏
页码:832 / 837
页数:6
相关论文
共 50 条
  • [1] Are there multiple pathways in the pathogenesis of Huntington's disease?
    Aronin, N
    Kim, M
    Laforet, G
    DiFiglia, M
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1999, 354 (1386) : 995 - 1003
  • [2] Huntington's disease and related disorders
    Anderson, KE
    [J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 2005, 28 (01) : 275 - +
  • [3] Synaptopathy, circuitopathy and the computational biology of Huntington's disease
    Hannan, Anthony J.
    [J]. BMC BIOLOGY, 2018, 16
  • [4] Synaptopathy, circuitopathy and the computational biology of Huntington’s disease
    Anthony J. Hannan
    [J]. BMC Biology, 16
  • [5] Network Based Approaches to Investigate the Relationship of Metabolites Related to Huntington's Disease with Phenols in Olive Oil
    Christodoulou, Christiana C.
    Demetriou, Christiana A.
    Christou, Yiolanda
    Spyrou, George M.
    Zamba-Papanicolaou, Eleni
    [J]. NEUROTHERAPEUTICS, 2019, 16 (04) : 1353 - 1354
  • [6] Genetics of Huntington's disease and related disorder
    Burgunder, Jean-Marc
    [J]. DRUG DISCOVERY TODAY, 2014, 19 (07) : 985 - 989
  • [7] RNA Related Pathology in Huntington's Disease
    Neueder, Andreas
    Bates, Gillian P.
    [J]. POLYGLUTAMINE DISORDERS, 2018, 1049 : 85 - 101
  • [8] A computational model for the Huntington disease
    Sarbaz, Yashar
    Banae, Masood
    Gharibzadeh, Shahriar
    [J]. MEDICAL HYPOTHESES, 2007, 68 (05) : 1154 - 1158
  • [9] The roles of the ubiquitin-proteasome and autophagy-lysosome pathways in Huntington's disease and related conditions
    Ravikumar, B
    Sarkar, S
    Berger, Z
    Rubinsztein, DC
    [J]. CLINICAL NEUROSCIENCE RESEARCH, 2003, 3 (03) : 141 - 148
  • [10] Identification of Reproducible Metabolites for Parkinson's Disease Diagnosis using Clinical Data and Computational Modelling
    Luo, X.
    Liu, Y. J.
    Balck, A.
    Klein, C.
    Fleming, R.
    [J]. MOVEMENT DISORDERS, 2023, 38 : S647 - S648